JP Patent

JP5829615B2 — 増殖性障害およびｂｃｒ−ａｂｌ、ｃ−ｋｉｔ、ｄｄｒ１、ｄｄｒ２またはｐｄｇｆ−ｒキナーゼ活性によりもたらされる他の病態の治療方法

Assigned to ノバルティス アーゲー · Expires 2015-12-09 · 10y expired

What this patent protects

Patent listed against nilotinib-hydrochloride.

Drugs covered by this patent

Patent Metadata

Patent number
JP5829615B2
Jurisdiction
JP
Classification
—
Expires
2015-12-09
Drug substance claim
No
Drug product claim
No
Assignee
ノバルティス アーゲー
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.